NEWS
Jun 04, 2025

A Statement Regarding Peptide Sourcing

ADVISORY BULLETIN

The SSRP is a medical education institute. We do not sell peptides. Our platform serves as a global scientific forum which promotes peptide science alongside cellular medicine education and clinical applications. It enables open dialogue and innovation through its support of the highest ethical and legal standards.

Our mission is to “improve patient outcomes, together”. This includes informing you how to protect both your patients and your license. Please take the time to discern the differences in peptide sourcing. This information is crucial for the safety of your patients, and the legal risks to you and your practice.

RUO Peptides

Some companies solicit research-use-only (RUO) peptides that exist outside human drug approval and/or prescription requirements. These products are for laboratory, educational, and investigational purposes only, not clinical, therapeutic, or diagnostic applications. They are labeled “not for human use” or “for research use only” as a legal disclaimer in an attempt to remove liability from the manufacturer in the context of human administration. Clinically prescribing or administering RUO peptides — even if they are third-party tested — violates federal and state board of pharmacy laws. The FDA sees this as misbranding and distribution of unapproved new drugs, and it’s legally indefensible in a court of law. Providers can get sued, have their license suspended, and face jail time for offering RUO meds directly from their clinics.

What If They Claim They’re Not RUO?

Even when a vendor claims their peptides are “pharma-grade” or “direct from manufacturer,” unless they are a licensed pharmacy, they are not legally authorized to sell medications for human use — and neither 3rd-party testing nor disclaimers remove this liability.

Compounded Peptides

If you have specific questions about how to source peptides appropriately, please reach out to your preferred compounding pharmacy. If you do not have one, we have several listed publicly on our website. Compounding pharmacies exist inside of a highly regulated, prescription drug supply chain. If you cannot find a particular peptide within their formulary, ask about substitutes they offer. If they do not ship to your state, ask your local compounding pharmacist how you can support them in their efforts to continue providing legitimate custom peptides for patients.

In Summary

Online injectable peptides that are not received from a legitimate compounding pharmacy are illegal. Period. Clinics can get raided, and providers can get shut down, if they are found to be prescribing them and storing them with intent to use clinically.

Compounding pharmacies compound drugs for human use for individually identified patients pursuant to a medical provider’s prescription. They ship directly to the patient, and patients’ rights to peptide therapy are protected under federal patient personal use laws.

Please consult with your legal counsel to ensure that, if you’re going to provide appropriate clinical guidance on peptide therapy, you’re doing so in a way that protects your patient’s health and your ability to continue to better ensure their safety.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
VIDEO
Cellular Medicine Mondays
Oct 12, 2026
Ep. 109 - Anti-Ageing Mini Mastermind Part 2
Preview only
Journal Club – Episode 109

Anti-Aging Mini Mastermind Part 2

In Part 2 of our Anti-Aging Mini Mastermind series, Dr. Seeds explores how PGE2 signaling and cellular metabolism influence inflammation, cognitive function, and aging, connecting foundational research to emerging discoveries in immunometabolism.  (2026 Article) (2021 Article)

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
William Seeds, MD Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
Revisiting a Journal Club Article, “Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging.” Science. 2026  Why This Paper Matters Most of the senescence conversation over the past decade has centered on a familiar cast: senescent fibroblasts, endothelial cells, adipocytes, and the drugs designed to clear them. This paper, which I discuss in […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Oct 5, 2026
Ep. 108 - Dr. Seeds’ Office Hours
Preview only
Dr. Seeds’ Office Hours – Episode 108

Dr. Seeds’ Office Hours – Episode 108

Questions Answered:
1. ARA-290 for Post Op 47yo Male [0:53]
2. Cold Therapy and the Wim Hof Method [17:06]

Preview Only — Become a member for full access
Healthgevity Oct 2, 2026
Healthgevity Introduces hydraCELL+™, Featuring Formulation IP Developed by the Seeds Foundation for Cellular Research
BREAKING NEWS INTERLAKEN, N.J., [October 2, 2026] — Healthgevity, a practitioner-focused precision longevity nutrition company, announced the launch of hydraCELL+™, a cellular hydration and muscle-support formula built on proprietary formulation IP developed through the Seeds Foundation for Cellular Research and licensed to Healthgevity. The formula reflects the cellular medicine approach advanced by William Seeds, MD, and […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Sep 28, 2026
Ep. 107 - Anti-Ageing Mini Mastermind Part 1
Preview only
Journal Club – Episode 107

Mini Anti-Aging Mastermind Part 1: Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging

Part 1 of a special Mini Anti-Aging Mastermind inspired by the recent Science article exploring how impaired clearance of senescent neutrophils may contribute to age-related organ decline. Dr. Seeds begins breaking down the cellular mechanisms behind the research and what they reveal about the biology of aging. (Article Link)

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
William Seeds, MD Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
Why a Plucked Hair Follicle May Matter to the Future of Regenerative Medicine In this article, I return to a study that I discussed in a July Journal Club post. The study, published in Cells in 2024, investigated whether cells obtained from plucked, cryopreserved human hair follicles could be reprogrammed into induced pluripotent stem cells […]
READ ARTICLE
Peptide Therapy Certification 2026
The SSRP Peptide Therapy Certification course gives clinicians, researchers, and other healthcare providers a working method for applying Cellular Medicine principles to patient care through clinical peptide therapy. Across 19 faculty-led lessons, Dr. William Seeds and SSRP faculty, including Siobhan...
19 Lessons
15 hrs 43 min
View Course
VIDEO
Cellular Medicine Mondays
Sep 21, 2026
Ep. 106 - Peptide Support After Transplant: What to Consider First
Preview only
Dissecting Protocols – Episode 106

Peptide Support After Transplant: What to Consider First

Dr. Seeds explores how to protect graft integrity and identify the right cellular targets before considering peptide support in a patient six years post liver transplant.

Preview Only — Become a member for full access
SSRP Institute Sep 14, 2026
In Case You Missed it: FDA Approves Mounjaro (tirzepatide) for CVD
HEADLINE SCIENCE [Sept 14, 2026] – On August 28, 2026, the FDA expanded the indication for Mounjaro (tirzepatide), approving the dual GIP/GLP-1 receptor agonist to reduce the risk of major adverse cardiovascular events—including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke—in adults with type 2 diabetes at high cardiovascular risk. The decision makes tirzepatide the […]
READ NEWS
EVENT
Certification
September 10 - 11, 2027
Peptide Therapy Certification 2027
Four Seasons Resort Orlando at Walt Disney World, FL
COMING SOON
Certification
Peptide Therapy Certification 2027
COMING SOON

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.